-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/blood-pressure-in-adults-hypertension-screening-2007
December 15, 2007 - The following non-pharmacological therapies are associated with reductions in blood pressure:
Reduction … Other Relevant Recommendations from the USPSTF
Adults with hypertension should be screened for diabetes … Clinicians should consider the patient's overall cardiovascular risk profile, including smoking, diabetes … Nonpharmacological treatment. … Nonpharmacological therapies, such as reduction of dietary sodium intake, potassium supplementation,
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary10/aspirin-for-the-prevention-of-cardiovascular-disease-preventive-medication
March 15, 2009 - We extracted the following data: geographic location, duration of therapy, proportion of female patients … , dosage, control, blinding, outcome adjudication, additional therapies, demographic characteristics, … 29%) 60-69 (45%) 70-79 (24%)
Mean, 54.6 45-54 (60.2%) 55-64 (29.5%) ≤65 (10.3%)
Duration of therapy … high and the original randomization process did not seem to account for the presence or absence of diabetes … Diabetes Care 2003;26:3264-72. [PMID: 14633812]
Return to Table of Contents
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/t6yV6ZMHngeWgmTsoMMefM
March 01, 2009 - We extracted the following
data: geographic location, duration of therapy, proportion
of female patients … , dosage, control, blinding, outcome ad-
judication, additional therapies, demographic characteris-
tics … , 50–80) 60–69 (45%) 45–54 (60.2%)
70–79 (13.9%) 70–79 (24%) 55–64 (29.5%)
�65 (10.3%)
Duration of therapy … high and the
original randomization process did not seem to account for
the presence or absence of diabetes … Diabetes Care. 2003;26:3264-72.
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary10/aspirin-for-the-prevention-of-cardiovascular-disease-preventive-medication-2009
March 15, 2009 - We extracted the following data: geographic location, duration of therapy, proportion of female patients … , dosage, control, blinding, outcome adjudication, additional therapies, demographic characteristics, … 29%) 60-69 (45%) 70-79 (24%)
Mean, 54.6 45-54 (60.2%) 55-64 (29.5%) ≤65 (10.3%)
Duration of therapy … high and the original randomization process did not seem to account for the presence or absence of diabetes … Diabetes Care 2003;26:3264-72. [PMID: 14633812]
Return to Table of Contents
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
April 11, 2016 - , diabetes, and smoking. … Treatment and Dosage
The optimal dose of aspirin to prevent CVD events is not known. … No data exist on the role of aspirin therapy in racial/ethnic groups. … The American Diabetes Association suggests low-dose aspirin therapy for primary prevention in patients … Early Treatment Diabetic Retinopathy Study report 14. JAMA . 1992;268:1292-300.
21.
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/high-body-mass-index-children-adolescents-interventions
June 30, 2022 - youth who:
Have an eating disorder
Are pregnant or postpartum
Have medical conditions, such as diabetes … combination:
Behavioral-based interventions (e.g., behavior modification, cognitive behavioral therapy … measures (included only when weight-related measures are also reported): insulin resistance/blood glucose/diabetes … ) or other treatment-related harms reported in trials meeting inclusion criteria for intermediate or … Serious harms are events resulting in death, hospitalization, or the need for urgent medical treatment
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/obesity-in-children-and-adolescents-screening
June 30, 2022 - youth who:
Have an eating disorder
Are pregnant or postpartum
Have medical conditions, such as diabetes … combination:
Behavioral-based interventions (e.g., behavior modification, cognitive behavioral therapy … measures (included only when weight-related measures are also reported): insulin resistance/blood glucose/diabetes … ) or other treatment-related harms reported in trials meeting inclusion criteria for intermediate or … Serious harms are events resulting in death, hospitalization, or the need for urgent medical treatment
-
www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/food-insecurity-preventive-services
June 25, 2024 - Primary care–based and primary care–referrable interventions generally offer only limited “treatment” … American Diabetes Association. … Diabetes Care . 2021;44(Suppl 1):S7-S14.
47. … Benefits of Early Detection and Intervention and Treatment
Inadequate direct evidence about screening … Harms of Early Detection and Intervention and Treatment
Inadequate evidence on the harms of screening
-
www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/food-insecurity-screening
June 25, 2024 - Primary care–based and primary care–referrable interventions generally offer only limited “treatment” … American Diabetes Association. … Diabetes Care . 2021;44(Suppl 1):S7-S14.
47. … Benefits of Early Detection and Intervention and Treatment
Inadequate direct evidence about screening … Harms of Early Detection and Intervention and Treatment
Inadequate evidence on the harms of screening
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/atrial-fibrillation-screening-with-electrocardiography-august-2018
August 07, 2018 - Treatments and Interventions
Treatment of atrial fibrillation has 2 components: managing arrhythmia … Treatment with anticoagulant therapy reduces the incidence of stroke in patients with symptomatic atrial … The USPSTF found adequate evidence that treatment with anticoagulant therapy reduces the incidence of … The USPSTF also found adequate evidence that treatment of atrial fibrillation with anticoagulant therapy … Without treatment with anticoagulant therapy, patients with atrial fibrillation have an approximately
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/sTjqbTas6gW5pzaATpeBDn
January 01, 2013 - Diabetes
A secondary analysis of WHI found a decreased risk
for a new diagnosis of diabetes requiring … Choices included “pills for diabetes” and “insulin
shots for diabetes.” … Diabetes was thus determined via self-
report of a new physician diagnosis of diabetes treated with
pharmacologic … on the development of type 2 diabetes. … Nonsurgical Treatments for Urinary
Incontinence in Adult Women: Diagnosis and Comparative Effectiveness
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/cardiovascular-disease-enhanced-risk-assessment-non-traditional-risk-factors
September 26, 2024 - Does treatment guided by coronary artery calcium scoring lead to improved health outcomes? … What are the harms of treatment guided by coronary artery calcium scoring? … We will also analyze benefits and harms of treatment interventions by specific populations to the extent … and decision-making outcomes (e.g., prescribing and adherence to preventive cardiovascular disease treatments … modification resulting in unexpected or unwanted medical attention (e.g., major bleeding, development of diabetes
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/G7CCbu64mf-nCynBkHbFLA
July 01, 2012 - Food and Drug Admin-
istration include short-term treatment of menopausal
symptoms, such as vasomotor … for elevated
cholesterol levels, hypertension, and diabetes. … Estrogen and Estrogen with Progestin
Therapies for Postmenopausal Women. Silver Spring, MD: U.S. … Long-
term effects of conjugated equine estrogen therapies on domain-specific cognitive
function: results … Effects
of combination estrogen plus progestin hormone treatment on cognition and
affect.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/Wx_w92ukxeDvNShoRQXbhP
September 06, 2016 - Some evi-
dence from observational studies has explored the association be-
tween poorly controlled diabetes … However, there is insufficient evidence on screening for and
treatment of LTBI in persons with diabetes … It does not recommend systematic testing for LTBI among
persons who have diabetes, engage in harmful … Efficacy of various
durations of isoniazid preventive therapy for
tuberculosis: five years of follow-up … Adverse
events with 4 months of rifampin therapy or 9
months of isoniazid therapy for latent tuberculosis
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/aspirin-to-prevent-cardiovascular-disease-preventive-medication
May 14, 2020 - effect vary between a priori subgroups defined by age, sex, 10-year cardiovascular risk, diagnosis of diabetes … effect vary between a priori subgroups defined by age, sex, 10-year cardiovascular risk, diagnosis of diabetes … with other nonaspirin antithrombotic medications (e.g., warfarin)
Comparisons
Placebo or no treatment
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/carotid-artery-stenosis-screening-july-2014
July 08, 2014 - Other factors, including treatment and control of diabetes and hyperlipidemia, are also reported to be … beyond current standard medical therapy. … Prevalence of hypertension in CREST and the SAPPHIRE trial was 85% to 88%, prevalence of diabetes in … and benefit beyond standard preventive treatments based on traditional cardiovascular risk factors. … of medical and surgical treatments, including the potential incremental benefit of CEA.
-
www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/aspirin-use-to-prevent-cardiovascular-disease-and-colorectal-cancer-preventive-medication
January 30, 2020 - effect vary between a priori subgroups defined by age, sex, 10-year cardiovascular risk, or diagnosis of diabetes … effect vary between a priori subgroups defined by age, sex, 10-year cardiovascular risk, diagnosis of diabetes … with other nonaspirin antithrombotic medications (e.g., warfarin)
Comparisons
Placebo or no treatment
-
www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/aspirin-use-to-prevent-cardiovascular-disease-preventive-medication
January 30, 2020 - effect vary between a priori subgroups defined by age, sex, 10-year cardiovascular risk, or diagnosis of diabetes … effect vary between a priori subgroups defined by age, sex, 10-year cardiovascular risk, diagnosis of diabetes … with other nonaspirin antithrombotic medications (e.g., warfarin)
Comparisons
Placebo or no treatment
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/e6_WqcwDGhgT6bQfmk3Hqj
February 02, 2021 - Treatment
Medical and surgical options are available for treatment of carotid
artery stenosis. … disease and
often includes statins, antiplatelet medications, management of
hypertension and diabetes … These studies
included participants with cardiovascular disease risk factors such
as diabetes, hypertension … conducted during the 1990s.8 Many
study participants had hypertension, coronary artery disease, or
diabetes … factors for developing carotid artery stenosis are noted in the
recommendation, including hypertension, diabetes
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan29/diet-behavioral-counseling-primary-care-adults-2003
February 03, 2014 - hypertension or dyslipidemia)
Persons with known CVD, such that >50% of participants have known CVD or diabetes … maintenance, falls prevention, depression, cognitive functioning, or disease prevention other than CVD/diabetes … The USPSTF received several comments requesting that it include persons with diabetes in the review. … Although management of diabetes is outside the scope of the USPSTF (which considers preventive services … , not treatment and management), studies that enrolled participants with diabetes will be included as